Advise Saving Evenity for High-Risk Women With Osteoporosis
September 2019
Evenity (ee-VEN-ih-tee, romosozumab) is the first med to increase bone growth AND decrease bone breakdown in postmenopausal osteoporosis.
Other osteoporosis meds do one or the other. For example, Forteo (teriparatide) builds bone...and bisphosphonates (alendronate, etc) and Prolia (denosumab) slow bone breakdown.
Evenity is the first sclerostin inhibitor. It's an injectable monoclonal antibody that blocks this protein involved in bone metabolism.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive